无机硝酸盐对冠状动脉旁路移植术后缺血再灌注损伤的影响:一项随机对照试验
这项单中心、随机、双盲、安慰剂对照试验纳入82例接受体外循环冠状动脉旁路移植术的患者,术前口服硝酸钠(700 mg×2)或安慰剂。结果显示,硝酸盐组血浆硝酸盐和亚硝酸盐浓度升高,但72小时肌钙蛋白T释放及肾、肝、脑损伤生物标志物与安慰剂组无差异;围术期出血在硝酸盐组少18%(非预设结局)。结论:术前给予无机硝酸盐未影响心脏手术后的肌钙蛋白T释放或其他器官损伤血浆生物标志物。
要点
- 术前口服无机硝酸盐未能减少冠状动脉旁路移植术后的心肌损伤(肌钙蛋白T释放)。
- 硝酸盐组与安慰剂组的肾、肝、脑损伤血浆生物标志物相似。
- 围术期出血在硝酸盐组少18%,但该指标非预设结局,需谨慎解读。
核心结论
- 术前给予无机硝酸盐未影响冠状动脉旁路移植术后的肌钙蛋白T释放或其他器官损伤血浆生物标志物。
研究设计与样本
- 单中心、随机、双盲、安慰剂对照试验,纳入82例接受体外循环冠状动脉旁路移植术的患者。
- 术前口服硝酸钠(700 mg×2)或安慰剂(NaCl),收集术前至术后72小时的缺血再灌注损伤生物标志物及血浆硝酸盐和亚硝酸盐。
- 预设主要终点为肌钙蛋白T释放,次要终点为肾、肝、脑损伤生物标志物。
主要发现
- 硝酸盐组血浆硝酸盐和亚硝酸盐浓度较安慰剂组升高。
- 72小时肌钙蛋白T释放两组间无差异。
- 其他器官损伤血浆生物标志物两组间也相似。
- 围术期出血在硝酸盐组较对照组少18%,但出血不是预设结局参数。
临床怎么用
- 基于本试验,术前无机硝酸盐给药不应以减少心脏手术后缺血再灌注损伤为目的用于临床。
- 围术期出血减少18%为非预设结局,不能作为临床决策依据。
局限性
- 单中心研究,样本量82例。
- 围术期出血减少18%为非预设结局参数,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nitric oxide (NO) is an important signalling molecule in the cardiovascular system with protective properties in ischaemia-reperfusion injury. Inorganic nitrate, an oxidation product of endogenous NO production and a constituent in our diet, can be recycled back to bioactive NO. We investigated if preoperative administration of inorganic nitrate could reduce troponin T release and other plasma markers of injury to the heart, liver, kidney, and brain in patients undergoing cardiac surgery. METHODS: This single-centre, randomised, double-blind, placebo-controlled trial included 82 patients undergoing coronary artery bypass surgery with cardiopulmonary bypass. Oral sodium nitrate (700 mg×2) or placebo (NaCl) were administered before surgery. Biomarkers of ischaemia-reperfusion injury and plasma nitrate and nitrite were collected before and up to 72 h after surgery. Troponin T release was our predefined primary endpoint and biomarkers of renal, liver, and brain injury were secondary endpoints. RESULTS: Plasma concentrations of nitrate and nitrite were elevated in nitrate-treated patients compared with placebo. The 72-h release of troponin T did not differ between groups. Other plasma biomarkers of organ injury were also similar between groups. Blood loss was not a predefined outcome parameter, but perioperative bleeding was 18% less in nitrate-treated patients compared with controls. CONCLUSION: Preoperative administration of inorganic nitrate did not influence troponin T release or other plasma biomarkers of organ injury in cardiac surgery. CLINICAL TRIAL REGISTRATION: NCT01348971.
引用
- Eriksson KE, Eidhagen F, Liska J, et al. Effects of inorganic nitrate on ischaemia-reperfusion injury after coronary artery bypass surgery: a randomised controlled trial. Br J Anaesth. 2021. PMID: 34399982. doi:10.1016/j.bja.2021.06.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。